Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biofrontera Inc.

Clinical trials sponsored by Biofrontera Inc., explained in plain language.

Biofrontera Inc. BFRI NASDAQ

A biopharmaceutical company focused on dermatological treatments, including photodynamic therapy for skin conditions.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 2

New light therapy could zap skin cancer without surgery

Disease control Ongoing

This Phase 3 trial tests whether a gel called Ameluz® combined with a special red light can effectively treat superficial basal cell carcinoma, a common skin cancer. About 187 adults with at least one lesion are enrolled. The main goal is to see if the treated skin cancer clears …

Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC